Previous 10 | Next 10 |
Revelation Biosciences (NASDAQ: REVB) , a clinical-stage life sciences company focused on the development of immunologic based therapies for the prevention and treatment of disease, announced its entry into a definitive agreement with a leading health care-focused institutional investor. Un...
SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatme...
SAN DIEGO, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatme...
SAN DIEGO, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatme...
SAN DIEGO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatme...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Happy Friday, trader! We’re starting off the day with an overview of the biggest pre-market stock movers for today! Source: f11photo/Shutterstock.com Moving stocks this morning are earnings reports, Covid-19 ...
-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple standard in vitro anti-viral activity assay systems- -Previously announced SPAC merger closes, Revelation Biosciences, Inc. publicly listed on the...
-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple standard in vitro anti-viral activity assay systems- -Previously announced SPAC merger closes, Revelation Biosciences, Inc. publicly listed on the...
OLNEY, Md., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Sandy Spring Bancorp, Inc. (NASDAQ: SASR, “Sandy Spring”) and Revere Bank (OTCQX: REVB, “Revere”) jointly announced that the companies have received the requisite stockholder approvals for Sandy Spring to complete the...
Revere Bank ( OTCQX:REVB ): Q4 GAAP EPS of $0.65 misses by $0.03 . More news on: Revere Bank, Earnings news and commentary, Financial stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Revelation Biosciences Inc. Company Name:
REVB Stock Symbol:
NASDAQ Market:
Revelation Biosciences Inc. Website:
2024-06-25 06:18:00 ET 3 Ways That the 2024 Election Can Impact Penny Stocks Elections can significantly influence financial markets, including the domain of penny stocks . Penny stocks, often traded below five dollars per share, present a unique opportunity for investors aiming for...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
-Top-line data forthcoming- Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced ...